Daily Stock List
GrowLife, Inc. (PHOT)
MomentumOTC, SmallCapVoice, and TopStockAnalysts reported recently on GrowLife, Inc. (PHOT), Wealth Daily, MoneyTV, Pennybuster did earlier, and we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Headquartered in Woodland Hills, California, GrowLife, Inc. has core holdings in creative technology-based products and services for the indoor gardening industry and specialty markets. GrowLife is a holding company for technology companies that make and market progressive grow technology products and life style products in America. GrowLife is a completely legal provider of highly effective indoor growing technologies that service the blossoming marijuana industry.
GrowLife's Brands include Stealth Grow LED, producer of hi-powered LED grow light products for indoor horticulture (www.stealthgrow.com), Greners.com, the online hydroponics superstore (www.greners.com) and Phototron, producer of hydroponic grow containers, designed to grow vegetables, herbs, flowers and fruits in any environment (www.phototron.com). The Company also has their Cannabis.org. This is an information portal for the medical marijuana industry hosted and developed by GrowLife. GrowLife is also the U.S. distributor for the Urban Cultivator brand—the greens machine (www.urbancultivator.net).
Their companies also include SGSensors.com. They are an operating division of SG Technology that manufactures and markets wireless monitoring and control equipment to operate all major grow room functions. GrowLife also has their GrowLife Productions. This business unit's dedication is to the promotion of GrowLife's core brands through co-production and co-sponsorship of entertainment, lifestyle, music, and film events across the U.S. GrowLife has their GrowLife Hydro that owns and operates specialty hydroponics stores in Los Angeles (Southern California) and Cotai (Northern California).
Earlier this month, GrowLife announced that they signed a Letter Of Intent (LOI) to acquire Rocky Mountain Hydroponics, LLC, Evergreen Garden Center, LLC, and 58Hydro.com (EGC) in a transaction that involves a combination of common stock, debt securities, as well as cash. The signed agreement will bring more than $4 million in EGC revenue to GrowLife's revenue.
This week, GrowLife announced the Company's support for House Bill 1523, the "Respect State Marijuana Laws Act of 2013." Congressman Dana Rohrabacher (R-CA) and a bi-partisan group of U.S. representatives have introduced legislation that could end the enforcement of federal marijuana laws in states that have either legalized it or adopted medical marijuana laws.
GrowLife, Inc. (PHOT), closed Friday's trading session at $0.0415, down 5.68%, on 5,386,370 volume with 217 trades. The average volume for the last 60 days is 9,285,423 and the stock's 52-week low/high is $0.01/$0.25.
FreeSeas, Inc. (FREE)
Stock Analyzer, The Street, and SmarTrend Newsletters reported recently on FreeSeas, Inc. (FREE), and we report on the Company today, here at the QualityStocks Daily Newsletter.
Incorporated in 2004, FreeSeas, Inc. is a drybulk shipping company. FreeSeas, by way of their subsidiaries, engages in the transportation of drybulk cargoes along global shipping routes. They transport different drybulk commodities, such as iron ore, grain, coal, bauxite, phosphate, fertilizers, steel products, cement, sugar, and rice. FreeSeas is a holding company; their subsidiaries, all wholly owned by the Company, conduct all of their operations and own all of their operating assets. FreeSeas has their headquarters in Athens, Greece.
The Company currently owns and operates a fleet of six Handysize vessels and one Handymax vessel. Under spot charters, FreeSeas pays voyage expenses including port, canal and fuel costs. Under period time charters, the charterer pays these voyage expenses. A spot charter and a period time charter are contracts to charter a vessel for an agreed period at a set daily rate. As of October 12, 2012, the aggregate deadweight tonnage (dwt) of FreeSeas operational fleet is approximately 197,200 dwt and the average age of their fleet is 15 years.
Under both spot charters and period time charters, FreeSeas is responsible for vessel operating expenses. These expenses include crew costs, provisions, deck and engine stores, lubricating oil, insurance, maintenance, as well as repairs. In addition, FreeSeas is responsible for each vessel's intermediate dry-docking and special survey costs. FreeSeas investment and operational focus is in the Handysize sector. This sector is normally defined as less than 40,000 dwt of carrying capacity.
The Company may occasionally employ their vessels in carrier pools. These pools (third party operated) bring together vessels from one or multiple owners to service charterers' requirements. Voyage and operating expenses are paid by the pool manager. FreeSeas would be paid their share of the voyage revenues on a predetermined schedule.
The majority of FreeSeas vessels were acquired second-hand. The Company estimates their useful lives to be 28 years from their date of delivery from the yard, depending on diverse market factors and Company management's ability to comply with government and industry regulatory requirements. Part of FreeSeas' strategy includes the continued acquisition of second hand vessels when they find attractive opportunities.
FreeSeas, Inc. (FREE), closed Friday's trading session at $1.07, down 3.17%, on 147,072 volume with 277 trades. The average volume for the last 60 days is 569,246 and the stock's 52-week low/high is $0.62/$15.90.
Blue Earth, Inc. (BBLU)
PennyStocks24, SmallCapStockPlays, and RedChip reported this week on Blue Earth, Inc. (BBLU), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Blue Earth, Inc. is an energy efficiency and renewable energy services company. Headquartered in Henderson, Nevada, they offer products and services that will optimize energy use, reduce harmful environmental emissions, and substantially reduce energy costs to their customers. Blue Earth engages in a mergers and acquisition strategy in the clean-tech industry. The Company's primary focus is acquiring companies and innovative technologies that serve the multi billion dollar energy efficiency services and renewable energy market sectors.
Their targeted technologies typically include different measures designed for a specific customer or facility in their target market of small commercial businesses and residences to improve the efficiency of building systems (refrigeration, lighting and heating, ventilation, and air conditioning). Company management plans to accelerate the introduction of the acquired technology/products by offering and installing them by way of energy management service companies and manufacturers representatives that have an established base of customers at the local, state, regional, and national levels.
Castrovilla, Inc. is a subsidiary of Blue Earth. Castrovilla is expanding their energy efficiency retrofit model into Southern California, Oregon, Washington, Nevada, Arizona, Utah, and Idaho. The business expansion will use the Blue Earth Energy Management Services (BEEMS) trade name.
Blue Earth has an agreement with Genesis Fluid Solutions, Ltd. (GFS). The GFS patented Rapid Dewatering System (RDS) removes different types of debris, sediments, and contaminants from waterways and industrial sites.
This week, Blue Earth announced that their wholly owned subsidiary, Xnergy was awarded the plant operation and preventive maintenance contract for a CHP power plant owned by KYOCERA America, Inc. KYOCERA is a leader in semiconductor and microelectronic packaging products. Under the two-year agreement, Xnergy will provide the Operation and Preventative Maintenance (O&M) service necessary to keep the equipment in good operating order at KYOCERA's San Diego location. The energy plant electrical capacity is 5.3 MW.
Xnergy provides a wide spectrum of complete energy solutions. These include the design and implementation of energy savings projects, energy conservation, energy infrastructure outsourcing, power generation, as well as energy supply and risk management.
Blue Earth, Inc. (BBLU), closed Friday's trading session at $1.47, up 1.38%, on 168,002 volume with 82 trades. The average volume for the last 60 days is 50,025 and the stock's 52-week low/high is $0.82/$1.75.
U.S. Silver & Gold, Inc. (USGIF)
TaglichBrothers reported earlier on U.S. Silver & Gold, Inc. (USGIF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
U.S. Silver & Gold, Inc. is a silver and gold mining company whose shares trade on the OTCQX International. The Company's focus is on growth from their existing asset base and the execution of targeted accretive acquisitions. U.S. Silver & Gold is the second largest primary silver producer in the U.S. They have a current expected annual rate of silver production of 2.6-2.8 million ounces. They expect to grow to 5 million ounces by 2015. U.S. Silver & Gold has their headquarters in Toronto, Ontario.
The Company owns and operates the Galena Mine Complex in the heart of the Silver Valley/Coeur d'Alene Mining District, Shoshone County, Idaho, and the Drumlummon Mine Complex in Lewis and Clark County, Montana. Within the Galena Mine Complex, the Galena Mine produces high-grade silver. It is the second most prolific silver mine in U.S. history, delivering more than 200 million ounces so far.
The Coeur Mine is under re-development with first production achieved in late 2012; the Caladay Zone is undergoing evaluation for bulk mining development. The Drumlummon Mine presently produces high-grade gold and silver with historical production of 1 million ounces of gold and 12 million ounces of silver. It has never been fully exploited or explored.
In late March, U.S. Silver & Gold reported year-end financial and operational results for 2012. For the full year 2012, they reported revenues of $94.9 million; adjusted net income of $4.7 million or $0.08 per share prior to a $14.4 million non-cash impairment charge related to the Drumlummon Mine and one-time, merger-related expenses, and a net loss of $17.8 million, or $0.29 per share. They also reported production of 2.57 million silver ounces at cash costs of $18.33 per ounce with the Drumlummon Mine consolidated for the full fiscal year 2012.
In 2012, U.S. Silver & Gold replaced proven and probable reserves of 23.2 million ounces, and reported measured and indicated resources of 13.0 million ounces (8 percent increase), and inferred resources of 14.4 million ounces as at December 31, 2012, and an additional 4.0 million ounces of inferred resources as at March 19, 2013 (versus 13.1 million ounces as at December 31, 2011). The Company is forecasting silver production in 2013 to grow approximately 10-15 percent to 2.7-3.0 million ounces. They are projecting silver cash costs of $17.00 to $19.00 per ounce.
U.S. Silver & Gold, Inc. (USGIF), closed Friday's trading session at $0.8781, up 8.18%, on 104,371 volume with 43 trades. The average volume for the last 60 days is 49,693 and the stock's 52-week low/high is $0.7061/$2.6755.
Citadel EFT, Inc. (CDFT)
Pumps and Dumps, Stock Analyzer, First Microcap Report, WallstreetSurfers, OTCPicks, Stocktwiter, and Nebula Stocks reported on Citadel EFT, Inc. (CDFT), and we highlight the Company, here at the QualityStocks Daily Newsletter.
Based in Oceanside, California, Citadel EFT, Inc. provides credit card terminals and merchant account services to retailers, mail order companies, as well as online service providers in North America. The Company is an Independent Contractor for National Payment Processing. Citadel EFT has approximately 1,700 merchant-clients that use their terminals to process their credit card transactions. Citadel EFT markets their services directly and via resellers. The Company's shares trade on the OTC Markets' OTCQB.
Founded in 1989, the Company mainly makes their money on "residuals". The basis of residuals is off a pre-negotiated and contracted percentage rate for each transaction that their merchant-client incurs by their customers. The Company has a standard contract. However, the rates at which they have negotiated with each of their merchant-clients may vary slightly.
Citadel EFT primarily generates revenues from the electronic processing of credit, charge, and debit card transactions authorized and captured through third-party networks. Merchants are usually charged for these processing services based on a percentage of the dollar amount of each transaction and in some instances, additional fees are charged for each transaction. Certain merchant customers are charged a flat fee per transaction and may be charged miscellaneous fees. These include fees for handling charge backs, monthly minimums, equipment rentals, sales or leasing, and other miscellaneous services.
The Company has no monthly or yearly fees, no monthly minimums, no statement fees, no address verification fees, and low-priced monthly internet-processing fees. They provide a client a free terminal of their choice. They will set a client up for web processing as well.
This past February, Citadel EFT Chief Executive Officer, Mr. Gary DeRoos, announced that Citadel EFT will start to assist other micro cap issuers in amending their corporate and capital structures, and reorganize debt obligations in exchange for convertible preferred stock compensation. Many micro cap issuers have contacted Citadel EFT this year looking for assistance to restructure their companies corporately. Citadel EFT will provide specific consulting expertise in the area of corporate restructuring, distressed asset purchasing, and debt reorganization.
Today, Mr. Gary DeRoos, announced that all common shareholders as of record date May 13, 2013 will be issued Anti-Dilutive Convertible Preferred 'D' Securities by May 23, 2013.
Citadel EFT, Inc. (CDFT), closed Friday's trading session at $0.01, up 1.01%, on 3,603,947 volume with 54 trades. The average volume for the last 60 days is 3,476,960 and the stock's 52-week low/high is $0.001/$0.13.
Vestas Wind Systems A/S (VWDRY)
We are reporting on Vestas Wind Systems A/S (VWDRY) today, here at the QualityStocks Daily Newsletter.
Vestas Wind Systems A/S engages in the manufacture and sale of wind turbines and wind power systems around the world. Vestas began in a small farming town in 1898. During the first quarter of 2012, Vestas passed 50 GW of installed capacity. This consolidated their position as the world’s leading manufacturer of wind power solutions. The Company has installations in more than 70 countries. Vestas Wind Systems is based in Denmark. The Company lists on the OTC Pink Current Information.
Vestas Wind Systems develops, and manufactures and markets wind turbines that generate electricity. In addition, the Company installs the turbines and offers follow-up and maintenance services of the installations. Vestas produces the windmills and its components via subsidiaries and associated companies in many countries, as well as operates a global sales and service network.
Last week, Vestas announced that they received a 299 MW order in Canada. The customer is a joint venture of EDF Renewable Energy and Enbridge, in the Province of Alberta. The Project name is the Blackspring Ridge Wind Project. The order is for 166 V100-1.8 MW turbines.
The contract scope includes the supply and commissioning of the wind turbines, a VestasOnline® Business SCADA system, and a 20-year service and maintenance agreement (AOM 5000). It is a supply-only contract. The scheduling of deliveries is for the second half of this year. The expectation is that commissioning will take place mid-2014.
This week, Vestas Wind Systems appointed Marika Fredriksson as new Chief Financial Officer (CFO) and member of the Executive Management. Marika Fredriksson will assume the position as CFO of the Company on May 1, 2013. She has wide-ranging experience in the CFO role, with 15 years in different industries and companies including Gambro (2009-2012), Autoliv (2008-2009) and Volvo Construction Equipment (1996-2008).
Vestas will disclose their interim financial report for Q1 2013 on May 8, 2013 at 8.30 CET.
Vestas Wind Systems A/S (VWDRY), closed Friday's trading session at $2.57, up 5.76%, on 364,121 volume with 67 trades. The average volume for the last 60 days is 23,670 and the stock's 52-week low/high is $1.30/$3.17.
Virtual Piggy, Inc. (VPIG)
Real Pennies, PennyTrader Publisher, Wallstreetlivechat, and FeedBlitz reported earlier on Virtual Piggy, Inc. (VPIG), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.
Headquartered in Hermosa Beach, California, Virtual Piggy, Inc. is an innovator in safe youth payments. They are the first e-commerce solution that enables kids to manage money and control their own wallet within a parent-controlled environment. A technology company, Virtual Piggy delivers online security platforms designed for the Under 18 age group in the worldwide online market. The Company lists on the OTC Bulletin Board.
Additionally, Virtual Piggy enables online businesses the ability to function in a manner consistent with the Children's Online Privacy Protection Act (COPPA) and comparable international children's privacy laws. The Company enables the Under 18 audience to play, transact and socialize in a secure online environment guided by parental permission, oversight and control.
Virtual Piggy allows parents to set up a monthly allowance for their children. The Company promotes financial management while empowering youth under 18 to make purchasing, saving, and other money management decisions for themselves, within the boundaries setup by parents.
Last week, the Company announced that they integrated their technology with the Oracle ATG Web Commerce leading ecommerce solution. This expands the reach of their network, making their COPPA-compliant technology accessible to more than 390,000 brands around the world. This is Virtual Piggy's fourth major ecommerce system integration following eBay's Magento platform, OsCommerce and DemandWare.
This week, Virtual Piggy announced that they expanded their Board of Directors to add three independent board directors with extensive software industry knowledge and experience. Mr. William Lyons has more than 20 years experience at the Chief Executive Officer level of public and private software companies.
Mr. William Tobia has more than 25 years experience at the Chief Financial Officer (CFO) level of software companies. This includes his current role as the CFO of Maxwell Systems. Mr. Harold Copperman has more than 40 years experience in the computer hardware and software industry. This includes 20 years experience at IBM.
Virtual Piggy, Inc. (VPIG), closed Friday's trading session at $2.14, up 4.39%, on 363,216 volume with 156 trades. The average volume for the last 60 days is 133,308 and the stock's 52-week low/high is $0.715/$2.50.
Speedemissions, Inc. (SPMI)
Penny Stock Rumble, OTCPicks, Top Gun, and The Stock Psycho, reported previously on Speedemissions, Inc. (SPMI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Speedemissions, Inc. is a foremost vehicle emissions testing and safety inspections company. They provide services in certain areas where the Environmental Protection Agency (EPA) mandates auto testing. The EPA has a mandate that selected major urban areas of 32 states and the District of Columbia (D.C.) meet certain clean air standards through conducting vehicle emission tests representing 50 percent of the U.S. population.
Speedemissions has their corporate headquarters in Atlanta, Georgia. They launched the first apps (CARbonga and CARbonga-SRI) for the iPhone®, iPad® and iPod Touch® that provides motorists with key safety and emissions information for their current vehicles or when buying a used car. The Company is currently expanding their business by selling SpeedEmissions Car Care Store Franchises and providing an emissions repair business division.
The Company formed to develop their own vehicle emission testing stations, and to make strategic acquisitions of selected competitors in markets identified for future growth. Their business is to conduct the vehicle emission or smog tests and safety inspections for automobiles, vans, sport utility vehicles (SUVs) and pick up trucks.
Speedemissions expects to be the first company to create a national brand offering their customers efficient and fast vehicle emissions testing service. Their present focus is in the Atlanta, Georgia; Houston, Texas; St. Louis, Missouri and Salt Lake City, Utah markets. They currently own and operate vehicle emission/safety inspection-testing stations.
Earlier this month, Speedemissions announced their financial results for the year ended December 31, 2012. Revenue decreased (6.8 percent) or $569,390, from $8,321,991 in the 2011 year to $7,752,601. The reduction in revenue is mainly because of a (3.4 percent) drop in same store customers and a reduction in fees per customer of (4.0 percent). Moreover, the Company sold two underperforming stores during the fourth quarter of 2012.
Speedemissions had a loss from operations for the year ended December 31, 2012, of ($534,549) and a net loss of ($656,037), or ($0.02) per basic and diluted share. This is in comparison to an operating loss of ($1,564,572) and a net loss of ($1,578,591), or ($0.05) per basic and diluted share in the prior year.
Speedemissions, Inc. (SPMI), closed Friday's trading session at $0.0093, up 32.86%, on 5,593,198 volume with 258 trades. The average volume for the last 60 days is 45,466 and the stock's 52-week low/high is $0.006/$0.0384.
Rafarma Pharmaceuticals, Inc. (RAFA)
The QualityStocks Daily Newsletter would like to spotlight Rafarma Pharmaceuticals, Inc. (RAFA). Today, Rafarma Pharmaceuticals, Inc. closed trading at $0.22, up 29.41%, on 50,675 volume with 8 trades. The stock’s average daily volume over the past 60 days is 9,677, and its 52-week low/high is $0.0501/$0.98.
Rafarma Pharmaceuticals, Inc. (RAFA) is a multiproduct pharmaceutical company specializing in the production of generic antibiotics and specialty pharmaceuticals, including its own proprietary products approved by the ministry of health. Rafarma stands as one of the most ambitious projects in recent medical history, having constructed the most technologically advanced pharmaceutical plant in Russia.
Based in Terbuny, Lipetsk region, Russia, Rafarma possesses a unique niche in the burgeoning pharmaceutical market and is poised to become a major player in the international drug industry. The company was established under the auspices of the Foundation to Support Health Care and has been approved by the Ministry of Health.
Rafarma recently received the general license for pharmaceutical products and began manufacturing three new products: Sodium Para-Aminosalicilate, Ibuprofen, and Betagistin. Receiving the general license was one of the final steps the company needed to open its new plant in Terbuniv, and Rafarma has been named one of only four national strategic pharmaceutical suppliers to the Russian Federation.
Advances in health care science, medicine, and technology have increased the general life expectancy of Eastern European citizens steadily over the past decade. Elderly citizens, which comprise the largest portion of the pharmaceuticals market, have bolstered demand for pharmaceuticals nationwide. Rafarma is well positioned to capitalize on the expanding industry with its strong relationships and state-of-the-art production facility. Disclaimer
Rafarma Pharmaceuticals, Inc. Company Blog
Rafarma Pharmaceuticals, Inc. News:
Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
Rafarma Pharmaceuticals Registers CEFTRIAXONE Under International Label
Rafarma Pharmaceuticals, Inc. Receives General License for Pharmaceutical Products and has Started to Manufacture 3 New Products
Cardium Therapeutics, Inc. (CXM)
The QualityStocks Daily Newsletter would like to spotlight Cardium Therapeutics, Inc. (CXM). Today, Cardium Therapeutics, Inc. closed trading at $0.0684, up 2.86%, on 357,868 volume with 346 trades. The stock’s average daily volume over the past 60 days is 346,967, and its 52-week low/high is $0.0618/$0.295.
Cardium Therapeutics, Inc. (CXM) is a health sciences and regenerative medicine company focused on acquiring and strategically developing new and innovative products and businesses to address significant unmet medical needs. Comprised of large-market opportunities with definable pathways to commercialization, partnering, and other economic monetizations, Cardium's current portfolio includes the Tissue Repair Company, Cardium Biologics, and the company's in-house MedPodium Health Sciences healthy lifestyle product platform.
The company's lead commercial product Excellagen® topical gel for wound care management recently received FDA clearance for marketing and sale in the United States. In addition to plans to advance the product's commercialization in the U.S. and internationally via strategic partnerships, the company plans to develop new product extensions for additional wound healing applications and is working towards securing approval for marketing and sale in South Korea and through the CE Mark application process in the European Union.
Generx®, Cardium's lead clinical development product candidate, is a DNA-based angiogenic biologic designed to treat patients with myocardial ischemia due to coronary artery disease. Cardium recently initiated its Generx Phase 3 / registration study in Russia. Consistent with its capital-efficient business model, Cardium is also actively evaluating new technologies and business opportunities. The company utilizes its team's skills in late-stage product development to bridge the critical gap between promising new technologies and product opportunities that are ready for commercialization.
Cardium is dedicated to building on its core products and product candidates to continually create new opportunities for greater success. Leveraging the advantages of its capital-efficient, asset-based business strategy, the company provides a diversified and more balanced portfolio of risk/return opportunities with the chief objective of providing long-term shareholder value. Disclaimer
Cardium Therapeutics, Inc. Company Blog
Cardium Therapeutics, Inc. News:
Cardium Receives ISO Certification for Excellagen
Cardium's To Go Brands® to Launch Expanded VitaRocks® kids Vitamin Line With New Retail Distribution
Cardium's Excellagen® Awarded American Podiatric Medical Association Seal of Approval, Company Also Announces Addition of a Regional Distributor for Excellagen
Loans4Less.com, Inc. (LFLS)
The QualityStocks Daily Newsletter would like to spotlight Loans4Less.com, Inc. (LFLS). Today, Loans4Less.com, Inc. closed trading at $0.15, up 11.11%, on 5,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 5,766, and its 52-week low/high is $0.01/$0.39.
Loans4Less.com, Inc. (LFLS) is an online mortgage broker which matches qualified individuals seeking mortgage loans with suitable lenders who offer the company a competitive wholesale lending program. Maintaining an A+ TrustLink rating with the Better Business Bureau, the company provides competitive rates, terms, costs, daily updates, extensive market information, and trusted first-class service to the public.
Leveraging its portfolio of 62 different web domains, Loans4Less.com is focused on developing a national consumer platform for conforming residential mortgage programs and implementation of other consumer loan programs via operating providers. The company's expansion strategy includes rapidly growing revenues through strategic and cost-effective advertising, licensing, and/or third party agreements that build national recognition of the Loans4Less® brand.
The management team has accumulated many years of experience in the real estate and financial services sectors. This combination of expertise provides the knowledge and foresight necessary to get the best results for the company and their thousands of loyal clients. The team skillfully navigated through the credit crisis that destroyed much of their competition, putting the company in a stronger position to increase market share.
Loans4Less.com is not exposed to the risks and/or problems that are associated with sub-prime lending. Having never defaulting on an obligation or been involved in any litigation, the company is poised for rapid growth in today's low interest rate environment with its industry leading reputation and well established relationships with respected lenders. Disclaimer
Loans4Less.com, Inc. Company Blog
Loans4Less.com, Inc. News:
Loans4Less.com Ranked in List as a Top Residential Loan Originator 2012
Loans4Less.com Expects to Achieve Fully Reporting Status by 2014
Loans4Less.com Launches New Advertising Campaign to Reach a Potential 1.7 Million
Soul and Vibe Interactive, Inc. (SOUL)
The QualityStocks Daily Newsletter would like to spotlight Soul and Vibe Interactive, Inc. (SOUL). Today, Soul and Vibe Interactive, Inc. closed trading at $0.296, up 0.34%, on 1,200 volume with 3 trades. The stock’s average daily volume over the past 60 days is 237,013, and its 52-week low/high is $0.26/$1.45.
Soul and Vibe Interactive, Inc. (SOUL) is a publisher of games and game-related content for consoles, mobile devices, and personal computers. The company specializes in creating original intellectual properties and has extensive experience licensing world-renowned brands from influential companies. Notably, Soul and Vibe is the only company with the right to license General Mills brands for video game applications.
Leveraging partnerships with software developers around the world, Soul and Vibe transforms unique concepts into engaging and affordable entertainment experiences. The game publisher has established game development and publishing agreements for the Xbox 360® video game and entertainment system, Windows 8, Windows Live, and Windows Phone from Microsoft, and the PlayStation® 3 computer entertainment system and PlayStation® Vita (PS Vita) from Sony.
Soul and Vibe stands out from the crowd by breaking through marketplace clutter and noise via direct-to-consumer tactics that reverberate from the core player to the mainstream gaming audience. Making games as fun to talk about as they are to play is a key focus of the company. The more personable and memorable the play experience, the more likely consumers and press will talk about the game and its publisher.
The burgeoning game industry spans across diverse demographics and offers wide-ranging opportunities for profit and growth. Consumer spending on console, mobile, and personal computer game software exceeded $56 billion in 2010 and is projected to reach $82 billion by 2015. This revenue represents more than 2x the size of the music industry and nearly 3/5th the size of the entire film industry. Disclaimer
Soul and Vibe Interactive, Inc. Company Blog
Soul and Vibe Interactive, Inc. News:
Soul and Vibe to Build Micro-Transactions Into Its Console, Mobile, and PC Games
Soul and Vibe to Pursue Business Development Deals at Game Connection Conference in San Francisco
Soul and Vibe to Monetize Avatars to Create Marketing Impressions and Additional Revenues
When Cardium Therapeutics recently released their 2012 financial results, reflecting the company’s extensive investment required for the important introduction of Excellagen and nutraceutical initiatives, and the initiation of their Generx ASPIRE clinical study, the standout feature of the report was the extensive list of achievements put in place to drive Cardium’s long-term growth strategy.
Cardium is actively advancing its Generx DNA-based angiogenic growth factor therapeutic, a one-of-a-kind treatment for heart blood flow problems which, unlike other treatments, actually stimulates blood vessel growth in the heart. Closer to market is the company’s Excellagen wound treatment product, which will eventually help support the Generx program. Cardium’s nutraceutical initiatives, centered around the company’s recent acquisition of To Go Brands, are already providing the significant source of income.
Relating to Generx, the report indicated that Cardium has successfully initiated a phase 3 registration study, and has published important Generx findings in the peer-reviewed journal Human Gene Therapy Methods. The company made a presentation at the 2013 Phacilitate Annual Cell & Gene Therapy Forum held in Washington, DC, and has also received a favorable patent decision in Europe, along with a successful resolution of a competition over rights to key methods for the application of cardiovascular gene therapy in the treatment of coronary heart disease.
The report also highlighted a number of accomplishments related to Cardium’s continuing progress in the commercialization of its FDA-cleared Excellagen product, a wound treatment gel that has been shown to significantly improve healing for many types of wounds. Cardium has now entered into a logistics and cold chain services agreement with Smith Medical Partners, and has been awarded ISO certification to market and sell Excellagen in the U.S. The company has also advanced international registrations.
Separately, Cardium has now established a strong foothold in the revenue-generating nutraceutical industry, through its successful acquisition of To Go Brands nutraceutical supplement platform, with over 25 products being developed and sold through established regional and national food, drug, and mass channel retailers at over 10,000 retail locations. In addition, the company has developed a new in-house partner-enabled product opportunity, LifeAgain, a set of algorithms and programs to support specialized survivable risk life insurance underwritings for cancer patients and patients with chronic medical diseases.
For additional information, visit www.CardiumTHX.com
When considering the recent progress made by International Stem Cell Corporation in the development of dramatic new approaches for the treatment of Parkinson’s disease, it’s easy to forget the impact such a technology could have on people around the world, and the potential size of the industry it could spawn. Though the exact cause of Parkinson’s disease is not known, the ultimate effect is the destruction of critical dopamine generating cells in the brain. The resulting impairment in nerve operation leads to progressive problems with motor functions, and eventually other debilitating effects.
According to the Parkinson’s Disease Foundation, as many as a million people in the U.S. alone are estimated to have Parkinson’s disease, with roughly 60,000 new cases diagnosed each year. On a worldwide basis, as many as 10 million people could be afflicted, though it is believed that many cases go undetected, at least initially. The costs of dealing with Parkinson’s is imposing, totaling roughly $25 billion annually in the U.S., with individual therapeutic surgery costing up to $100,000 per patient. Although there has been some success treating the early motor symptoms of Parkinson’s through attempts to chemically replace missing dopamine, the efficacy of the treatment decreases over time.
For these reasons, the initial success that ISCO has had using its proprietary parthenogenetic stem cells has caught the attention of many people both in and out of the medical establishment. Though still in the animal study stage, indications are that neuronal cells, generated from the company’s parthenogenetic pluripotent stem cells, can be safely introduced and successfully treat Parkinson’s symptoms. It’s something never before accomplished, opening the door to the possibility of an entirely new treatment option.
For additional information, visit www.InternationalStemCell.com
Voice Assist, the award-wining mobile speech solutions developer, is poised to grab immense market share with their Apple SIRI-like, cloud-based, and platform-agnostic virtual assistant engine that promises to also save countless lives out of the 1.2M who perish every year worldwide in car accidents, many of which are due to distractions like using the cell phone while behind the wheel.
With over 600M passenger cars on the road today and upwards of 6B wireless phones, Voice Assist is a much needed solution that can call (including dial by name), two-way text, email (listen/reply), or even post to Facebook/Twitter, all via voice command. The company launched a mobile app for Android in September of last year and released a version for Apple iOS just three months after, giving Voice Assist broad reach across millions of smartphones, PCs, tablets, and even IPTV, something which gives VSST a significant leg up over competitors.
With success in the initial market trials, teaming up with heavyweights Sprint and AT&T to help land over 15k subscribers to the promoted freemium version in just two months, VSST is already working on a third party developer SpeechApp store to bring in additional content. By sharing 30% of the revenue with carriers, the company is rapidly integrating itself and will quickly be migrating freemium users to either the 100 minutes for $4.95 per month, or $9.95 for unlimited personal use plan (free version allows 25 minutes or 10 messages per month)
VSST is sitting on nine key patents pending for their one-touch continuous speech solution, and the solution is already fully integrated with the popular Jabra Freeway, an in-car, Bluetooth speakerphone, which features Virtual Surround Sound and voice-guided assistance. Again this is choice positioning for VSST as the Jabra Freeway was rated “product of the year” by TMCnet, the world’s top B2B and integrated marketing media company, as well as taking home “best of show” at CTIA (The Wireless Association®), the event hosted by the esteemed international nonprofit membership organization which has represented the wireless communications industry since 1984.
In addition to this incredible marvel of the hands-free speech area, VSST has compelling offerings like a flat-rate $19.95 per month IP-based home phone service, something which dovetails perfectly with the Voice Assist platform, making it like having SIRI on your home phone. This same package is available for small business as well, with an upgrade to the $25 per month package enabling the Mandi, virtual receptionist feature.
Also in the hopper at VSST is the Voice Assist for Salseforce.com upgrade, allowing salespeople to create database entries with a simple phone call after they get done talking to the customer. This solution has already been fully certified and tested for stringent, business-class security.
With 32 different countries now banning cell phone use while driving, the demand for VSST’s technology is set to keep pace with the white-hot mobile market and investors will be keen to see how quickly the apps and services continue to take off.
To learn more about Voice Assist, visit www.VoiceAssist.com
According to a recently issued press release, Scio Diamond Technology is to be featured on the Fox Business News show “Built in America.” Additionally, Scio announced fiscal year ending production status.
Scio, in concert with Studio 1080, was very pleased to report its upcoming feature on “Built In America” airing on Fox Business Network, April 28 at 2:30 PM. “This is a very exciting time for Scio,” remarked Michael McMahon, Scio’s CEO. “To be selected as a featured article on the premier showing of Built in America is a great opportunity for Scio Diamond to show Fox’s 68 million-viewer audience our one-of-a-kind technology.”
“While filming the Scio Diamond feature, we were truly amazed at this diamond making technology and impact it will have in the future to all of us,” said Mr. Collin Williams, Executive Producer / Director of Studio 1080. “It was astounding to actually watch diamond growing and learn the many, many uses of diamond.”
Scio Diamond’s first year of operation and fiscal year ended March 31st 2013. Over the last year Scio has designed and built a production facility in Greenville, SC, and since relocated all production equipment from Massachusetts to their Greenville location. Production began in July and over that nine months Scio has produced over 15,000 carats of lab-grown single crystal rough diamonds. Scio has been earning revenue since September of 2012.
“It has been an exciting first year of operation,” says Michael McMahon. “Our staff has worked endless hours, 7 days a week to bring our facility to this point.” Scio produced 275 carats of single crystal lab grown diamond a week in its first quarter of operation alone. The average production in the last quarter (January – March 2013) for Scio exceeded 600 rough carats of single crystal diamond per week.
“The demand of product continues to be very high in both the gemstone and industrial market segments,” says McMahon. “Even though we are convinced that our one of kind technology produces more diamond per reactor than any other technology, we are far from our ultimate production levels.”
Scio currently employs a patent-protected chemical vapor deposition process to produce their high-quality, single-crystal diamonds in a controlled laboratory setting. With identical visual properties to that of a mined diamond, Scio produces high quality colorless, near colorless, and fancy colored diamonds.
For more information, visit www.sciodiamond.com
Today's Top 3
Penny Stocks VIP
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Advaxis, Inc. (ADXS) to Present at the BIO International Convention
- Consorteum Holdings, Inc. (CSRH) Enters Partnership Agreement With KO Entertainment, Inc.
- Cardium Therapeutics, Inc. (CXM) Receives ISO Certification for Excellagen
- GlobalWise Investments, Inc. (GWIV) CEO to Speak at Technology United Executive Conference
- International Stem Cell Corp. (ISCO) Announces Fourth Quarter 2012 Financial Results and Provides Business Update
- Loans4Less.com, Inc. (LFLS) Ranked in List as a Top Residential Loan Originator 2012
- Rafarma Pharmaceuticals, Inc. (RAFA) Announces Engagement of QualityStocks Investor Relations Services
- Rainbow Coral Corp. (RBCC) Nears Deal With Leading Genetic Testing Lab
- Soul and Vibe Interactive Inc. (SOUL) to Pursue Business Development Deals at Game Connection Conference in San Francisco
- The Aristocrat Group Corp. (ASCC) Looks to Apple, Social Media to Promote New Brands
- The Guitammer Company Inc. (GTMM) Joins D-Tools Manufacturer Vantage Point (MVP) Program
- VentriPoint Diagnostics Ltd. (VPTDF) Receives CE Mark for Major Expansion of Its VMS™ Platform for Right Heart Analysis
- Viaspace, Inc. (VSPC) and AGRICORP Partnership on Giant King Grass in Nicaragua: 12MW Biomass Power Plant Targeted
- VistaGen Therapeutics, Inc. (VSTA) Announces $36 Million Strategic Financing Agreement